Cointime

Haystack Oncology

company

About

Haystack Oncology enables precision oncology to optimize treatment strategies.

Highlights

Total Funding Amount
$56M
Funding Rounds
1
Investors
4
Employee Profiles
4

Details

Last Funding Type
Series A
Last Funding Money Raised
$56M
Industries
Biotechnology,Medical
Founded date
Jan 1, 2021
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Haystack Oncology, Inc.
Also Known As
Haystack

Haystack Oncology, an oncology company, uses the most recent circulating tumor DNA detection technology to enhance the diagnosis of minimum residual disease and provide superior therapy decision-making information.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$56M
Haystack Oncology has raised a total of $56M in funding over 2 rounds. Their latest funding was raised on Nov 16, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 16, 2022 Series A $56M 4 Catalio Capital Management — Detail

Investors

Number of Lead Investors
Number of Investors
1
4
Haystack Oncology is funded by 4 investors. Catalio Capital Management and Alexandria Venture Investments are the most recent investors.
Investor Name Lead Investor Funding Round
Catalio Capital Management Yes Series A
Alexandria Venture Investments — Series A
Bruker — Series A
Exact Ventures — Series A

Employee Profiles

Number of Employee Profiles
4
Haystack Oncology has 4 current employee profiles, including Board member George Petrocheilos
George Petrocheilos
Board member
Jacob Vogelstein
Board member
Isaac Ro
Board member
Joel Kaufman
Executive
Cointime
เนื้อหา
บริษัท